Print Print
CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.

Tiredness/fatigue in adults - Management
View full scenario

Overview of management

  • Establish a supportive therapeutic relationship, taking the person's complaint seriously and adopting a holistic approach.
  • Try to identify an underlying cause, bearing in mind that tiredness may be caused by one or a combination of physical, psychosocial, and physiological factors, or may be unexplained.
    • Look for any red flags.
    • Consider easily missed conditions, such as Addison's disease, carbon monoxide poisoning, coeliac disease, domestic abuse, haemochromatosis, hypopituitarism, medication, pregnancy, renal failure, and sleep apnoea (see the CKS topics on Carbon monoxide poisoning, and Sleep apnoea).
    • Consider any existing chronic illnesses, psychiatric history, and current or recent infections.
    • Take a history and do a physical examination (see Assessment).
    • Arrange appropriate investigations.
    • Consider the possibility of chronic fatigue syndrome/myalgic encephalomyelitis or encephalopathy (CFS/ME).
  • Consider whether referral is indicated.
  • Treat the underlying cause, if this is known.
  • Consider treatment strategies for people with persistent, unexplained fatigue.
  • In women of child-bearing age with a serum ferritin level of 50 micrograms/L or less without anaemia:
    • Identify the cause and consider offering iron supplementation (80 micrograms/day elemental iron) for at least 4 weeks (off-label indication).
Basis for recommendation

Therapeutic relationship

Identify the cause

Red flags

  • This recommendation is derived from a National Institute for Health and Clinical Excellence guideline on the diagnosis and management of chronic fatigue syndrome/myalgic encephalomyelitis or encephalopathy [National Collaborating Centre for Primary Care, 2007].

Easily missed diagnoses

Existing chronic illnesses, psychiatric history, and current or recent infections

  • This recommendation is based on:
    • Expert opinion from narrative reviews [Godwin et al, 1999; Rodriguez, 2000; Simon, 2008].
    • Evidence from a Canadian study that 93 people presenting to primary care with tiredness were significantly more likely to have a lifetime history of major depression or anxiety disorder compared with 593 controls [Cathebras et al, 1992].

When should I refer an adult with tiredness?

  • Referral to secondary care is likely to be required if a serious underlying physical cause is suspected or identified, such as Addison's disease, coeliac disease, HIV, hepatitis B or C, malignancy, renal failure, or sleep apnoea (see the CKS topic on Sleep apnoea).
  • Refer adults (18 years of age or older) with symptoms suggestive of chronic fatigue syndrome/myalgic encephalomyelitis or encephalopathy (CFS/ME) to specialist CFS/ME services:
    • Within 6 months of presentation, if symptoms are mild.
    • Within 3–4 months of presentation, if symptoms are moderate.
    • Immediately, if symptoms are severe.
  • Consider referring to secondary care those people with persistent, unexplained tiredness/fatigue not meeting the criteria for CFS/ME if any of the following apply:
    • There is significant uncertainty regarding the presence of an underlying physical cause.
    • The person would benefit from the reassurance of a second opinion or from the thoroughness of a secondary care evaluation, and referral is not likely to reinforce unrealistic beliefs in a physical cause.
    • The person may benefit from access to the structured and multidisciplinary care delivered by specialist CFS/ME services, or from a secondary care opinion for occupational reasons or disability benefits.
  • Children and young people 17 years of age or younger should be referred to paediatrics within 6 weeks of presentation, but are not included in the scope of this topic.
Basis for recommendation
  • The recommendations in relation to people with symptoms suggestive of chronic fatigue syndrome (CFS)/myalgic encephalomyelitis or encephalopathy (ME) are based on a National Institute for Health and Clinical Excellence guideline on the diagnosis and management of CFS/ME [National Collaborating Centre for Primary Care, 2007].
    • As well as comprehensive assessment, referral to specialist services provides access to cognitive behavioural therapy and graded exercise therapy, which NICE states are 'the interventions for which there is the clearest research evidence of benefit' in people with mild-to-moderate CFS/ME [National Collaborating Centre for Primary Care, 2007].
  • The recommendation that referral may be required if any other serious underlying cause is suspected or identified is pragmatic.
  • In the absence of published evidence, the recommendation on when to consider referral for people with persistent, unexplained tiredness/fatigue not meeting the criteria for CFS/ME is a compromise between the views of CKS expert reviewers, who were divided on the merits of referring this group of people to secondary care.

What treatments should I consider for an adult with tiredness?

  • Treat the underlying cause, if this is known.
  • In women of child-bearing age with serum ferritin of 50 micrograms/L or less but without anaemia:
    • Identify the cause and consider offering iron supplementation (80 mg/day elemental iron) for at least 4 weeks (off-label indication, based on limited evidence).
  • For all people with persistent unexplained fatigue, including those with suspected chronic fatigue syndrome (CFS)/myalgic encephalomyelitis or encephalopathy (ME):
    • Try to establish a supportive therapeutic relationship.
    • Try to offer an understandable explanation for tiredness/fatigue that:
      • Absolves the person from blame but also offers ways for the person to take, or at least share, responsibility for managing the symptom.
      • Is linked clearly to the person's specific concerns.
      • Provides links between psychosocial and physical factors.
    • Try to broaden the person's perception of tiredness/fatigue so that psychosocial causes and solutions are validated and considered along with biomedical causes.
    • Identify and address modifiable psychological, social, and general health factors, including stress, work, personal relationships, pain, and alcohol.
  • For people meeting criteria for CFS/ME who have not yet been assessed by specialist CFS/ME services:
    • Offer advice on sleep management.
      • Provide general advice on sleep hygiene — see the section on Good sleep hygiene in the CKS topic on Insomnia.
      • Discourage excessive sleep and daytime sleeping or naps.
    • In relation to activity, rest, and relaxation, advise:
      • Limiting the length of rest periods to 30 minutes at a time.
      • Introducing low level physical and cognitive activities (depending on the severity of symptoms).
      • Avoiding unsupervised, or unstructured, vigorous exercise.
      • Using relaxation techniques.
    • Advise a well-balanced diet.
    • Manage nausea by giving advice on eating little and often, snacking on dry starchy foods, and sipping fluids.
      • Use anti-emetic drugs only if nausea is severe.
  • For people with persistent unexplained fatigue (lasting 4 months or longer) who do not meet criteria for CFS/ME:
    • There is insufficient evidence to make any additional, clear recommendations, but the following treatment strategies may be considered:
      • Advise a balance between activity (including exercise) and rest.
      • Offer advice on sleep management — see the CKS topic on Insomnia.
      • Consider offering referral for counselling or cognitive behavioural therapy, if services are available and the person is motivated and psychologically minded.
      • Consider referring to specialist CFS/ME services for a structured, multidisciplinary approach to management, to access specialist interventions such as cognitive behavioural therapy and supervised graded exercise therapy, or for a consultant opinion for occupational reasons or disability benefits.
Basis for recommendation

Treat the cause

  • This is a pragmatic recommendation.

Iron supplementation

  • There is limited evidence from one randomized, placebo-controlled trial in 144 people, sponsored by industry, that iron supplementation significantly reduces self-reported fatigue in women 18–55 years of age without anaemia presenting to primary care with fatigue [Verdon et al, 2003]. Only women with ferritin concentrations of 50 micrograms/L or less improved with treatment. These findings have not been confirmed in any subsequent trials, and CKS expert reviewers were divided over the appropriateness of recommending iron supplementation in this group of people.

Therapeutic relationship

Explanation

  • These recommendations are derived from a qualitative study on the effectiveness of GPs' explanations to provide reassurance (normalization) to 36 people with unexplained symptoms in UK primary care [Dowrick et al, 2004].
    • Consultations between 21 GPs and 36 people with unexplained medical symptoms were audio-taped.
    • Transcripts were analysed for recurring ways that normalizing statements were presented by GPs and responded to by patients.
    • The suggested methods for explanation are based on the findings of this study.

Try to broaden the person's perception of fatigue

Modifiable psychological, social, and general health factors

People meeting the criteria for chronic fatigue syndrome (CFS)/myalgic encephalomyelitis or encephalopathy (ME)

People who do not meet the criteria for CFS/ME

  • Balance between activity and rest
  • Sleep management
    • This recommendation is pragmatic.
  • Counselling and cognitive behavioural therapy (CBT)
    • There is evidence from a randomized trial that, in people with severe fatigue for 4 months or longer and off work for 6–26 weeks, CBT delivered by a GP after 12 hours' training is no more efficacious than no active intervention [Huibers et al, 2004a].
    • CKS found no trials in people with persistent, unexplained fatigue (not diagnosed as CFS/ME) that compared CBT or counselling, delivered by qualified practitioners, with no treatment or placebo treatment. However, there is evidence from a randomized trial that, in people with unexplained fatigue lasting 3–4 months or longer, CBT is equivalent to counselling [Ridsdale et al, 2001].
      • Subsequently, it was reported that a better outcome was predicted by being psychologically minded and expressing, acknowledging, and accepting emotional distress [Chalder et al, 2003; Godfrey et al, 2007]. The authors recommended that GPs should assess these factors before referring people for psychological treatments.
    • Despite the findings of these studies, CBT is commonly recommended in narrative reviews for people with unexplained, persistent or chronic tiredness/fatigue [Ruffin and Cohen, 1994; Sharpe and Wilks, 2002; Dick and Sundin, 2003].
  • Graded exercise
    • CKS found no randomized, controlled trials in people with unexplained fatigue that have compared exercise with no treatment or placebo treatment, or compared one form of exercise with another.
      • There is evidence from one randomized trial that graded exercise is equivalent to cognitive behavioural therapy in reducing unexplained fatigue that has been present for 3 months or longer [Ridsdale et al, 2004].
  • Referral to specialist CFS/ME services
    • This recommendation is based on comments from CKS expert reviewers.

Prescriptions

For information on contraindications, cautions, drug interactions, and adverse effects, see the electronic Medicines Compendium (eMC) (http://emc.medicines.org.uk), or the British National Formulary (BNF) (www.bnf.org).

Iron preparations

Age from 18 years onwards
Ferrous sulphate tablets: 200mg (65mg iron) twice a day
Ferrous sulphate 200mg tablets
Take one tablet twice a day.
Supply 56 tablets.
Age: from 18 years onwards
NHS cost: £2.40
OTC cost: £4.20
Licensed use: no - off-label indication
Patient information: These tablets are usually well tolerated but may sometimes upset your stomach, causing sickness, heartburn, and possibly diarrhoea or constipation. These side effects should settle down with time, but if they are very troublesome at first you may reduce the dose to just one tablet each day. After 4 or 5 days, try increasing the number of tablets taken back up to twice a day. Taking the tablets with or after some food will also help reduce the side effects. This medicine may also colour your stools black. Keep these tablets out of the reach of children.
Ferrous fumarate tablets: 210mg (68mg iron) twice a day
Ferrous fumarate 210mg tablets
Take one tablet twice a day.
Supply 56 tablets.
Age: from 18 years onwards
NHS cost: £0.80
OTC cost: £1.42
Licensed use: no - off-label indication
Patient information: These tablets are usually well tolerated but may sometimes upset your stomach, causing sickness, heartburn, and possibly diarrhoea or constipation. These side effects should settle down with time, but if they are very troublesome try taking the tablets with or after some food to help reduce the side effects. Trying an alternative iron salt is another option. This medicine may also colour your stools black. Keep these tablets out of the reach of children.
Ferrous fumarate capsules: 305mg (100mg iron) once a day
Ferrous fumarate 305mg capsules
Take one capsule once a day.
Supply 28 capsules.
Age: from 18 years onwards
NHS cost: £0.50
OTC cost: £0.89
Licensed use: no - off-label indication
Patient information: These capsules are usually well tolerated but may sometimes upset your stomach, causing sickness, heartburn, and possibly diarrhoea or constipation. These side effects should settle down with time, but if they are very troublesome try taking the capsules with or after some food to help reduce the side effects. Trying an alternative iron salt is another option. This medicine may also colour your stools black. Keep these capsules out of the reach of children.
Ferrous fumarate tablets: 322mg (100mg iron) once a day
Ferrous fumarate 322mg tablets
Take one tablet once a day.
Supply 28 tablets.
Age: from 18 years onwards
NHS cost: £0.79
OTC cost: £1.39
Licensed use: no - off-label indication
Patient information: These tablets are usually well tolerated but may sometimes upset your stomach, causing sickness, heartburn, and possibly diarrhoea or constipation. These side effects should settle down with time, but if they are very troublesome try taking the tablets with or after some food to help reduce the side effects. Trying an alternative iron salt is another option. This medicine may also colour your stools black. Keep these tablets out of the reach of children.
Ferrous gluconate tablets: 300mg (35mg iron) three times a day
Ferrous gluconate 300mg tablets
Take one tablet three times a day.
Supply 84 tablets.
Age: from 18 years onwards
NHS cost: £2.10
OTC cost: £2.50
Licensed use: no - off-label indication
Patient information: These tablets are usually well tolerated but may sometimes upset your stomach, causing sickness, heartburn, and possibly diarrhoea or constipation. These side effects should settle down with time, but if they are very troublesome at first you may reduce the number of tablets you take each day to just one or two. After 4 or 5 days, try increasing the number of tablets taken back up to three a day. Taking the tablets with or after some food will also help reduce the side effects. This medicine may also colour your stools black. Keep these tablets out of the reach of children.

© NHS Institute for Innovation and Improvement